AbbottABT announced the availability of FreeStyle LibreLink app in Europe for use in smartphones(both iPhone and Android). Notably, diabetes patients using the ...
MISSISSAUGA, Ontario, Oct. 4, 2018 /CNW/ -- Abbott (NYSE: ABT) announced today the company has received the Health Canada license of its FreeStyle LibreLink mobile app for use with compatible iOS ...
Abbott on Thursday launched its digital health tool, FreeStyle LibreLink app in India. The mobile app allows people who use the FreeStyle Libre system to measure their glucose readings on their mobile ...
In order to further the mission to simplify diabetes management, Abbott announces a first-of-its-kind mobile app that will enable people with diabetes to access glucose data directly from their ...
Using near-field communication (NFC) technology, the app transfers glucose data from the sensor to the mobile device, allowing users to track their eight-hour glucose history and real-time patterns ...
New authorization from Health Canada allows FreeStyle Libre system to be used by frontline healthcare workers in hospitals to remotely monitor patients' glucose status to minimize exposure during ...
People with diabetes who use a widely-used app to monitor their blood sugar levels have been left stranded after the software stopped functioning on certain Apple devices following an update. The ...
Abbott ABT announced the availability of FreeStyle LibreLink app in Europe for use in smartphones(both iPhone and Android). Notably, diabetes patients using the ...
US-based global healthcare leader Abbott has launched its digital health tool, FreeStyle LibreLink app in India. The mobile application will allow people who use the FreeStyle Libre system to measure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback